… I would like to acknowledge the dedicated individuals who prepared the Workshop
Report and the effective leadership of the Workshop Chair, Professor Romain Pauwels. It is …

Chronic obstructive pulmonary disease is a leading cause of death and disability, but has
only recently been extensively explored from a cellular and molecular perspective. There is a …

For most patients, asthma is not controlled as defined by guidelines; whether this is achievable
has not been prospectively studied. A 1-year, randomized, stratified, double-blind, parallel…

Background The role of long-acting, inhaled β 2 -agonists in treating asthma is uncertain. In
a double-blind study, we evaluated the effects of adding inhaled formoterol to both lower and …

Background and Methods Although patients with chronic obstructive pulmonary disease (COPD)
should stop smoking, some do not. In a double-blind, placebo-controlled study, we …

Chronic obstructive pulmonary disease (COPD) is a major cause of chronic morbidity and
mortality and represents a substantial economic and social burden throughout the world. It is …

Background Although inhaled glucocorticosteroids are recommended for persistent asthma,
their long-term effect on recent onset, mild, persistent asthma has yet to be established. …

Antigen transport from the airway mucosa to the thoracic lymph nodes (TLNs) was studied
in vivo by intratracheal instillation of fluorescein isothiocyanate (FITC)-conjugated …

Antagonizing the effect of interleukin (IL)-5 is a potential new treatment strategy in allergic
disorders. We evaluated the safety, biological activity, and pharmacokinetics of SCH55700 , a …

… RA Pauwels, AS Buist, P Ma, CR Jenkins, SS Hurd; GOLD Scientific Committee …